A dual receptors-targeting and size-switchable “cluster bomb” co-loading chemotherapeutic and transient receptor potential ankyrin 1 (TRPA-1) inhibitor for treatment of triple negative breast cancer
Yashi Wang, Sheng Yin, Lin Mei, Yiliang Yang, Shanshan Xu, Xuan He, Mou Wang, Man Li, Zhirong Zhang, Qin He
Topics & Concepts
ChemistryCancer researchIn vivoTumor microenvironmentPharmacologyBiologyBiotechnologyTumor cellsIon Channels and ReceptorsNeuropeptides and Animal PhysiologyBioactive Compounds and Antitumor Agents